OpenScience.ink

2 days ago • Critical pathways in cardiology

Semaglutide’s effects on heart-related deaths: a systematic review and analysis of heart protectionSemaglutide and Cardiovascular Death: a Systematic Review and Meta-Analysis Cardioprotective Efficacy of Semaglutide.

Article

4 days ago • Psychiatry and clinical psychopharmacology

Could Incretin Receptor Agonists Be Used as Psychiatric Medicines Soon or Is That an Overstatement?Are Incretin Receptor Agonists Psychiatric Drugs: Near-term Opportunity or Creative Superlative?

Article

5 days ago • Medicina clinica

Benefits of semaglutide on daily activities and health in very old patients with heart failure, type 2 diabetes, and obesityActivities of daily living and health status benefits of semaglutide in very old patients with heart failure, type 2 diabetes, and obesity: Real-world practice study.

📖 Top 50% JournalArticle

6 days ago • Rambam Maimonides medical journal

Brain and mental health safety of GLP-1 receptor drugs and tirzepatide in adults with type 2 diabetes or obesityNeuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity.

📖 Top 50% JournalArticle

1 week ago • Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Glucagon-like-peptide-1 receptor agonists and their impact on major heart and blood vessel health outcomesEffect of glucagon-like-peptide-1 receptor agonists on major cardiovascular outcomes: a systematic review and meta-analysis.

Article

2 weeks ago • Omics : a journal of integrative biology

Comparing Oral and Injectable Incretin-Based Weight Loss Treatments: A Combined Data Analysis of Orforglipron, Semaglutide, and TirzepatideOral Versus Injectable Incretin-Based Anti-Obesity Therapies: An Integrated Computational and Evidence-Based Comparison of Orforglipron, Semaglutide, and Tirzepatide.

📖 Top 50% JournalArticle

2 weeks ago • Cardiology in review

Tirzepatide’s effects on obstructive sleep apnea, heart and metabolism health, and what this means for heart careTirzepatide for Obstructive Sleep Apnea: Trial Evidence, Cardiometabolic Effects, and Implications for Cardiovascular Practice.

📖 Top 50% JournalArticle

2 weeks ago • Journal of vitreoretinal diseases

Glucagon-Like Peptide-1 Receptor Agonists and Their Link to Risk of Blocked Blood Vessels in the RetinaThe Impact of Glucagon-Like Peptide-1 Receptor Agonists on Risk of Retinal Vascular Occlusions.

📖 Top 50% JournalArticle

2 weeks ago • Journal of diabetes and metabolic disorders

Short-term cost-effectiveness of tirzepatide, semaglutide, and liraglutide for treating obesity and overweight without diabetes in IranEconomic evaluation of tirzepatide, semaglutide, and liraglutide in the treatment of obese and overweight patients without diabetes: a short-term cost-effectiveness analysis in Iran.

📖 Top 50% JournalArticle

2 weeks ago • Missouri medicine

Metabolic Surgery Compared to Glucagon-Like Peptide-1 Drugs for Treating Obesity and Related Health ProblemsThe Great Debate: Metabolic Surgery vs. Glucagon-Like Peptide-1 Receptor Agonists in Managing Patients with Obesity and its Related Comorbid Medical Illnesses.

📖 Top 50% JournalArticle

2 weeks ago • The Libyan journal of medicine

Pharmacy students' knowledge and views on side effects of GLP-1 medicines for treating obesityPharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.

📖 Top 50% JournalArticle

2 weeks ago • Journal of doctoral nursing practice

Use of Tirzepatide and Semaglutide for Prediabetes and Heart-Related Health in Rural Primary CareA Retrospective Chart Review of Tirzepatide and Semaglutide Use in Prediabetes Management and Cardiometabolic Outcomes in a Rural Primary Care Setting.

Article

2 weeks ago • Annals of Indian Academy of Neurology

Early Treatment with GLP-1 Receptor Agonists in Acute Stroke and High-Risk Mini-Stroke: A Review of Randomized TrialsEarly GLP-1 Receptor Agonist Therapy in Acute Ischemic Stroke and High-Risk Transient Ischemic Attack: A Systematic Review and Meta-analysis of Randomized Trials.

📖 Top 50% JournalArticle

3 weeks ago • Internal medicine (Tokyo, Japan)

Changes in Walking Speed Over 12 Months of Obesity Treatment with Semaglutide in Japanese Adults with Muscle and Joint ProblemsChanges in Gait Speed During a 12-Month Multidisciplinary Obesity Management Program Including Semaglutide: A Real-World Observational Study in Japanese Adults With Musculoskeletal Disorders.

Article

3 weeks ago • Journal of diabetes and metabolic disorders

What adult weight-loss drugs can teach us about treating childhood obesityThe pharmacotherapy for pediatric obesity: insights and challenges from adult weight-loss medications.

📖 Top 50% JournalArticle

3 weeks ago • IBRO neuroscience reports

How Hormones Control Appetite and Energy Balance in Metabolic DisordersNeuroendocrine regulation of appetite and energy balance in metabolic disorders.

📖 Top 30% JournalArticle

3 weeks ago • Revista espanola de enfermedades digestivas

Ischemic colitis linked to oral semaglutide with return after restarting the drugIschemic colitis associated with oral semaglutide with recurrence upon rechallenge.

Article

3 weeks ago • Translational and clinical pharmacology

How movement affects drug interactions with GLP-1 receptor agonists: clear evidence and a way to measure themMotility-mediated drug interactions with GLP-1 receptor agonists: labeled evidence and a framework for quantitative assessment.

📖 Top 50% JournalArticle

4 weeks ago • Journal of diabetes and metabolic disorders

Heart and blood vessel outcomes with tirzepatide compared to semaglutide in type 2 diabetesCardiovascular outcomes with tirzepatide versus semaglutide in type 2 diabetes.

📖 Top 50% JournalArticle

1 month ago • Turkish journal of surgery

How GLP-1 receptor drugs may affect cosmetic surgery practiceEffects of GLP-1 receptor agonists on aesthetic surgery practice: A contemporary review.

Article

1 week ago • Zhonghua yi xue za zhi

Effectiveness and safety of locally made semaglutide injections in type 2 diabetes patients not well controlled by metformin: a multicenter phase 3 trial[Efficacy and safety of domestic semaglutide injection in patients with type 2 diabetes mellitus inadequately controlled with metformin: a multicenter, randomized, controlled phase 3 equivalence clinical trial].

English Abstract

1 week ago • The Journal of the Association of Physicians of India

Healthcare Professionals' Views on Newer Weight Loss Drugs Semaglutide and Tirzepatide in South AsiaPerspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey.

Article

1 week ago • The Journal of the Association of Physicians of India

Practical Challenges and Factors Linked to Success in GLP-1 Receptor Agonist TreatmentReal-world Challenges and Predictors of Success in Glucagon-like Peptide-1 Receptor Agonist Therapy.

Article

2 weeks ago • Innere Medizin (Heidelberg, Germany)

Treating Type 2 Diabetes[Treatment of type 2 diabetes mellitus].

English Abstract

3 weeks ago • Acta gastroenterologica Latinoamericana

Digestive Side Effects of Drugs That Activate the Glucagon-Like Peptide-1 Receptor: A Complete ReviewGlucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review.

Article

1 month ago • Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Using GLP-1 and Dual GIP/GLP-1 Medicines for Obesity: Practical Advice for DoctorsPractical Considerations for the Use of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity: A Clinician-Oriented Guide.

Article

6 days ago • Endocrine

Comparing reported side effects of semaglutide and tirzepatide using FDA safety dataComparative adverse-event reporting patterns of semaglutide and tirzepatide: a disproportionality analysis of FAERS.

Comparative Study

2 weeks ago • Revista medica de Chile

Effectiveness of Weekly Semaglutide (0.5 or 1 mg) in Chilean Adults with Type 2 DiabetesEffectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.

Clinical Trial, Phase IV

3 weeks ago • BMJ medicine

Patient preferences and challenges starting newer diabetes medicines in adults with type 2 diabetesValues, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review.

Systematic Review

1 week ago • medRxiv : the preprint server for health sciences

Care Patterns After Starting Semaglutide or Tirzepatide and Their Links to Weight Loss in Obesity TreatmentPost-Initiation Care Patterns and Weight Loss With Semaglutide and Tirzepatide for Obesity in Clinical Practice.

Preprint

← prevpage 12 of 16next →

GLP-1 Therapies Research Papers